Pharma Focus Asia

Sol-Gel Technologies Enters into Licence Agreement with Searchlight Pharma

Wednesday, June 07, 2023

Sol-Gel Technologies and Searchlight Pharma have officially signed exclusive licence agreements for the distribution and commercialisation of TWYNEO and EPSOLAY in the Canadian market.

As part of the agreement, Sol-Gel will receive potential upfront payments and milestones totalling up to $11 million for two drugs. These payments may be associated with regulatory approvals and sales milestones. Additionally, Sol-Gel will be entitled to royalty percentages based on the net sales in Canada.

The initial term of the agreement spans fifteen years, with the possibility of renewal for subsequent five-year periods. This collaboration aims to make these advanced dermatological treatments widely available to Canadian consumers, addressing their specific skincare needs.

TWYNEO and EPSOLAY are two new dermatology products developed by Sol-Gel Technologies. With the signing of these agreements, both companies aim to bring innovative dermatological solutions to patients in Canada. 

TWYNEO is a combination cream that contains tretinoin (a retinoid) and benzoyl peroxide. It is used for the treatment of acne vulgaris in adults and paediatric patients 9 years of age and older. EPSOLAY is a cream that contains benzoyl peroxide at a concentration of 5 percent. It is specifically indicated for the treatment of inflammatory lesions associated with rosacea in adults.

magazine-slider-imageMFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopNitrosamine Advance Workshop 2024CPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024LogiPharma Asia 2024